{"id":3917,"date":"2012-11-15T16:38:38","date_gmt":"2012-11-15T16:38:38","guid":{"rendered":"http:\/\/www.medicalmarijuanainc.com\/?p=4157"},"modified":"2012-11-15T16:38:38","modified_gmt":"2012-11-15T16:38:38","slug":"medical-marijuana-inc-portfolio-company-canchew-biotechnologies-inc-announces-final-day-for-market-survey-and-free-product-trial-registration","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2012\/11\/15\/medical-marijuana-inc-portfolio-company-canchew-biotechnologies-inc-announces-final-day-for-market-survey-and-free-product-trial-registration\/","title":{"rendered":"Medical Marijuana Inc. Portfolio Company CanChew BioTechnologies Inc. Announces Final Day for Market Survey and Free Product Trial Registration"},"content":{"rendered":"
\n

SAN DIEGO, Nov. 15, 2012 \/PRNewswire\/ —\u00a0CanChew BioTechnologies Inc, a portfolio company of Medical Marijuana Inc. (OTC: MJNA), announces that this is the final day to register for the market trial of CanChew gum.\u00a0 Qualifying participants will receive a minimum of a 30-day free trial sample of the CBD-based CanChew gum in exchange for their product feedback.\u00a0 The only cost involved will be a nominal shipping charge of $4.95 for delivery of the product.<\/p>\n

While the company has been researching distribution partnerships for over-the-counter sales of the CanChew gum product, preparations for clinical trials have been underway in Europe and are slated to begin during 2013.\u00a0 U.S. clinical trials should begin shortly thereafter.\u00a0 Successful trials and new drug application may eventually lead to a European and\/or U.S. pharmaceutical product with substantiated medical claims. Over the counter sales of CanChew gum are expected to begin in the first quarter of 2013.<\/p>\n